LIPOPHILIC PROBES FOR TUMOR CELL SURFACES
用于肿瘤细胞表面的亲脂性探针
基本信息
- 批准号:3184252
- 负责人:
- 金额:$ 11.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-09-30 至 1988-07-31
- 项目状态:已结题
- 来源:
- 关键词:autologous transplantation bone marrow transplantation cell bank /registry cell membrane clone cells drug resistance electron microscopy hematopoietic stem cells human tissue membrane activity membrane lipids mutant myelogenous leukemia neoplasm /cancer chemotherapy neoplasm /cancer diagnosis neoplasm /cancer photoradiation therapy neoplastic cell tissue /cell culture
项目摘要
It has been known for some time that the lipid composition of the plasma
membranes of many neoplastic cells differs from the composition of their
normal counterparts. However, few attempts have been made to exploit this
difference for diagnostic and therapeutic purposes. It is the main
objective of this proposal to determine if the lipophilic, anionic dye,
merocyanine 540 (MC 540), can be employed to both identify and selectively
destroy leukemic cells. Flow cytometric analyses of MC 540 stained blood
samples from leukemia patients undergoing chemotherapy or bone marrow
transplantation will be performed to test the dye's potential as a
diagnostic agent. Two animal models of human acute myelogenous leukemia,
drug-resistant mutant cell lines and in vitro clonal cultures of normal and
leukemic human hematopoietic stem cells will be used to assess the dye's
ppotential as a means for the purging of residual tumor cells from
autologous remission marrow grafts. Attempts to elucidate some aspects of
the molecular mechanisms that underlie dye-mediated photosensitization will
be based on a combined light microscopic, electron microscopic, biochemical
and biological analysis of photosensitized cells. Analogs of MC 540 will
be employed to define the structural requirements of the staining reaction
and the photosensitization process. The proposed work could lead to an
earlier detection of leukemic relapse and thus to useful individualizations
of treatment. MC 540-mediated photosensitization may find an application
in the in vitro purging of residual tumor cells from autologous remission
bone marrow grafts.
一段时间以来,人们已经知道血浆的脂质组成
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Fritz Sieber其他文献
Fritz Sieber的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Fritz Sieber', 18)}}的其他基金
MEROCYANINE PHOTOPRODUCTS WITH ANTINEOPLASTIC ACTIVITY
具有抗肿瘤活性的部花青感光产品
- 批准号:
6350277 - 财政年份:1999
- 资助金额:
$ 11.03万 - 项目类别:
MEROCYANINE PHOTOPRODUCTS WITH ANTINEOPLASTIC ACTIVITY
具有抗肿瘤活性的部花青感光产品
- 批准号:
6497468 - 财政年份:1999
- 资助金额:
$ 11.03万 - 项目类别:
MEROCYANINE PHOTOPRODUCTS WITH ANTINEOPLASTIC ACTIVITY
具有抗肿瘤活性的部花青感光产品
- 批准号:
6150245 - 财政年份:1999
- 资助金额:
$ 11.03万 - 项目类别:
MEROCYANINE PHOTOPRODUCTS WITH ANTINEOPLASTIC ACTIVITY
具有抗肿瘤活性的部花青感光产品
- 批准号:
6794539 - 财政年份:1999
- 资助金额:
$ 11.03万 - 项目类别:
MEROCYANINE PHOTOPRODUCTS WITH ANTINEOPLASTIC ACTIVITY
具有抗肿瘤活性的部花青感光产品
- 批准号:
2829013 - 财政年份:1999
- 资助金额:
$ 11.03万 - 项目类别:
相似海外基金
Prevention of age-related hearing loss using bone marrow transplantation
利用骨髓移植预防与年龄相关的听力损失
- 批准号:
23K08999 - 财政年份:2023
- 资助金额:
$ 11.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Novel Bone Marrow Transplantation Approach for Sickle Cell Disease Using Targeted Marrow Irradiation
使用靶向骨髓照射治疗镰状细胞病的新型骨髓移植方法
- 批准号:
10737358 - 财政年份:2023
- 资助金额:
$ 11.03万 - 项目类别:
Tuning tyrosine kinase signalling to improve haematopoietic stem cell expansion and bone marrow transplantation
调节酪氨酸激酶信号传导以改善造血干细胞扩增和骨髓移植
- 批准号:
2889841 - 财政年份:2023
- 资助金额:
$ 11.03万 - 项目类别:
Studentship
A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
一项针对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者进行非亲缘供体骨髓移植与免疫抑制治疗比较的 III 期随机试验
- 批准号:
10722602 - 财政年份:2022
- 资助金额:
$ 11.03万 - 项目类别:
A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
一项针对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者进行非亲缘供体骨髓移植与免疫抑制治疗比较的 III 期随机试验
- 批准号:
10368246 - 财政年份:2022
- 资助金额:
$ 11.03万 - 项目类别:
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
1/2A III 期随机试验,比较无关供体骨髓移植与免疫抑制治疗对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者的影响
- 批准号:
10600143 - 财政年份:2022
- 资助金额:
$ 11.03万 - 项目类别:
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
1/2A III 期随机试验,比较无关供体骨髓移植与免疫抑制治疗对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者的影响
- 批准号:
10370775 - 财政年份:2022
- 资助金额:
$ 11.03万 - 项目类别:
The mycobiota, bone marrow transplantation, and clinical outcomes
真菌群、骨髓移植和临床结果
- 批准号:
10415200 - 财政年份:2021
- 资助金额:
$ 11.03万 - 项目类别:
The mycobiota, bone marrow transplantation, and clinical outcomes
真菌群、骨髓移植和临床结果
- 批准号:
10303678 - 财政年份:2021
- 资助金额:
$ 11.03万 - 项目类别: